![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/395 | (2006.01) |
A61K 31/519 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61K 31/505 | (2006.01) | ||
C07K 16/28 | (2006.01) |
(11) | Number of the document | 3302550 |
(13) | Kind of document | T |
(96) | European patent application number | 16725504.1 |
Date of filing the European patent application | 2016-05-25 | |
(97) | Date of publication of the European application | 2018-04-11 |
(45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
(46) | Date of publication of the claims translation | 2019-11-11 |
(86) | Number | PCT/EP2016/061744 |
Date | 2016-05-25 |
(87) | Number | WO 2016/189014 |
Date | 2016-12-01 |
(30) | Number | Date | Country code |
15169124 | 2015-05-26 | EP | |
15196860 | 2015-11-27 | EP |
(72) |
ENDELL, Jan, DE
BOXHAMMER, Rainer, DE
WINDERLICH, Mark, DE
|
(73) |
Incyte Corporation ,
1801 Augustine Cut-Off, Wilmington, Delaware 19803,
US
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Anti-CD19 antikūno ir Brutono tirozino kinazės inhibitoriaus derinys ir jo naudojimas |
COMBINATION OF AN ANTI-CD19 ANTIBODY AND A BRUTON`S TYROSINE KINASE INHIBITOR AND USES THEREOF |
Payment date | Validity (years) | Amount | |
2025-05-20 | 10 | 231.00 EUR |
2026-05-25 |